NEU Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Neuren Pharmaceuticals Ltd

Watchlist Manager

Watchlist

Price: 16.69 AUD 1.15%

Market Cap: AU$2.1B

	Neuren Pharmaceuticals Ltd ASX:NEU	AU
A	Ambev SA F:AMNA	BR
	Imugene Ltd ASX:IMU	AU
	Aegon NV F:AEND	NL
S	Seven West Media Ltd SWB:WA7	AU
	Duratec Ltd OTC:DURCF	AU
Z	Ziprecruiter Inc XBER:47R	US
V	Vodafone Group PLC SWB:VODI	UK
K	Kraken Robotics Inc F:2KQ	CA

Profitability Summary

Neuren Pharmaceuticals Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Exceptional Operating Margin

45%

Strong 3Y Average Operating Margin

75%

Declining Operating Margin

70% > 45%

Exceptional Net Margin

40%

Strong 3Y Average Net Margin

60%

Declining Net Margin

69% > 40%

Exceptional Free Cash Flow Margin

163%

Strong 3Y Average Free Cash Flow Margin

71%

Free Cash Flow Margin is Increasing

68% > 163%

Low ROE

Exceptional 3Y Average ROE

Exceptional 3Y Average ROIC

821%

Declining ROIC

968% > 23%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.